Beckley/Brazil Research Programme

In 2017 Amanda Feilding set up a collaborative programme with leading neuroscientists in Brazil to investigate how psychedelics may benefit human health, with a particular focus on neuroplasticity, anti-inflammation and neurogenesis mechanisms. Due to its remarkable ability to promote neuroplasticity, LSD  is a compound of choice for this research.

Pioneering research in areas of high unmet need

Moving between brain cells, mini-brains, animals and humans, this translational research programme will provide the basis to develop new treatments and therapies for neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases, but also depression, ADHD and brain injury rehabilitation. Pioneering research in areas of high unmet need.

A collaboration with top level neuroscientists

This image has an empty alt attribute; its file name is image-2.png

Prof Sidarta Ribeiro is vice-Director of the world-class Brain Institute at the University Federal of Rio do Norte (UFRN), member of the Academy of Sciences of Latin America and director of the Brazilian Society for the Progress of Science. He is an expert in neurobiology, neurophysiology and behavioural neuroscience.

Prof Stevens Rehen is a world renown neuroscientist specialized in stem cell research at the Federal University of Rio de Janeiro and at the prestigious D’Or Institute (IDOR). Stevens was a pioneer in culturing human induced pluripotent stem cells and brain organoids, or ‘minibrains’ in Brazil.

Promising preliminary  findings



Lab-grown ‘minibrains’ are simplified brains grown from stem cells that recreate 3D tissue structure and cellular composition of the brain in vitro. They are an extremely promising and valuable tool to model brain diseases such as Alzheimer’s and Parkinson’s, and can be used to screen new potential treatments.

Results are currently being peer-reviewed, but can already be read about in more detail here.


Vital need for support

The severe cuts in research budget undertaken by the new government seriously compromise the ability of our collaborators and other researchers in Brazil to continue their ground-breaking work (see this article for more information https://bit.ly/30H92pV).

More than ever, our colleagues in Brazil need support, and the Beckley Foundation is determined to raise funds in order to help them continue their pioneering work.

For this, the Beckley Foundation relies exclusively on the generosity of our supporters.